Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine; National University of Singapore (NUS) - Department of Microbiology and Immunology
Early detection of infections is crucial to limit the spread of coronavirus 2019 disease (COVID-19). Here, we developed a flow cytometry-based assay to detect SARS-CoV-2 Spike protein (S protein) antibodies in COVID-19 patients. The assay detected specific IgM and IgG in COVID-19 patients and also the acquisition of all IgG subclasses, with IgG1 being the most dominant. The antibody response was significantly higher at a later stage of the infection. Furthermore, asymptomatic COVID-19 patients also developed specific IgM and IgG, with IgG1 as the most dominant subclass. Although the antibody levels were lower in asymptomatic infections, the assay was highly sensitive and detected 97% of asymptomatic infections. These findings demonstrated that the assay could be used for serological analysis of symptomatic patients, and also as a sensitive tool to detect asymptomatic infections, which may go undetected.
Funding: Biomedical Research Council (BMRC), the A*ccelerate GAP-funded project (ACCL/19-GAP064-R20H-H) from Agency of Science, Technology and Research (A*STAR), and National Medical Research Council (NMRC) COVID-19 Research fund (COVID19RF-001, COVID-19RF-007, COVID-19RF-60).
Conflict of Interest: The authors declare no competing interests.
Ethical Approval: The study design and protocols for COVID-19, recovered SARS and seasonal human CoV patient cohorts were approved by National Healthcare Group (NHG) Domain Specific Review Board (DSRB) and performed, following ethical guidelines in the approved studies 2012/00917, 2020/00091 and 2020/00076 respectively. Healthy donor samples were collected in accordance with approved studies 2017/2806 and NUS IRB 04-140. Written informed consent was obtained from participants in accordance with the Declaration of Helsinki for Human Research.
Goh, Yun Shan and Chavatte, Jean-Marc and Jieling, Alicia Lim and Lee, Bernett and Amrun, Siti Naqiah and Lee, Cheryl Yi-Pin and Chee, Rhonda Sin-Ling and Wang, Bei and Lee, Chia Yin and Ngoh, Eve and Wang, Cheng-I and Young, Barnaby E. and Tambyah, Paul A. and Kalimuddin, Shirin and Pada, Surinder and Tan, Seow-Yen and Sun, Louisa and Chen, Mark I-Cheng and Leo, Yee-Sin and Lye, David Chien and Ng, Lisa F.P. and Lin, Raymond Tzer Pin and Renia, Laurent, Sensitive Detection of Total Anti-Spike Antibodies and Isotype Switching in Asymptomatic and Symptomatic COVID-19 Patients. Available at SSRN: https://ssrn.com/abstract=3713507 or http://dx.doi.org/10.2139/ssrn.3713507
This version of the paper has not been formally peer reviewed.
Subscribe to this fee journal for more curated articles on this topic
FOLLOWERS
1
PAPERS
401
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.
Download This Paper